🇺🇸 FDA
Patent

US 7547762

T24 antigen for immunodiagnosis of Taenia solium cysticercosis

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7547762 (T24 antigen for immunodiagnosis of Taenia solium cysticercosis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/00, A61K39/00